Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 31.


Ramanan, AV, Dick, AD, Jones, AP, McKay, A, Williamson, PR ORCID: 0000-0001-9802-6636, Compeyrot-Lacassagne, S, Hardwick, B, Hickey, H, Hughes, D, Woo, P
et al (show 3 more authors) (2016) ADALIMUMAB IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED UVEITIS: THE SYCAMORE TRIAL. .


Ramanan, AV, Dick, AD and Beresford, MW ORCID: 0000-0002-5400-9911
(2017) Adalimumab for Uveitis in Juvenile Idiopathic Arthritis. The New England journal of medicine, 377 (8). pp. 789-790.


Horton, S, Jones, AP, Guly, CM, Hardwick, B, Beresford, MW ORCID: 0000-0002-5400-9911, Lee, RWJ, Dick, AD and Ramanan, AV
(2019) Adalimumab in juvenile-idiopathic arthritis-associated uveitis (JIA-U): 5-year follow-up of the Bristol participants of the SYCAMORE trial. American journal of ophthalmology, 207. pp. 170-174.


Ramanan, AV, Dick, AD, Jones, AP, McKay, A ORCID: 0000-0003-1312-8911, Williamson, PR ORCID: 0000-0001-9802-6636, Compeyrot-Lacassagne, S, Hardwick, B, Hickey, H ORCID: 0000-0003-0467-0362, Hughes, D ORCID: 0000-0001-8247-7459, Woo, P
et al (show 4 more authors) (2017) Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis. New England Journal of Medicine, 376 (17). pp. 1637-1646.


Massias, JS, Smith, EMD, Al-Abadi, E, Armon, K, Bailey, K, Ciurtin, C, Davidson, J, Gardner-Medwin, J, Haslam, K, Hawley, DP
et al (show 14 more authors) (2020) Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups. LUPUS, 29 (5). pp. 474-481.


Smith, EMD, Yin, P, Jorgensen, AL ORCID: 0000-0002-6977-9337 and Beresford, MW ORCID: 0000-0002-5400-9911
(2018) Clinical predictors of active LN development in children - evidence from the UK JSLE Cohort Study. LUPUS, 27 (13). pp. 2020-2028.


Ramanan, AV, Hampson, LV, Lythgoe, H, Jones, AP, Hardwick, B, Hind, H, Jacobs, B, Vasileiou, D, Wadsworth, I, Ambrose, N
et al (show 11 more authors) (2019) Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO. PLOS ONE, 14 (6). e0215739-.


Smith, EMD
(2016) Developing a Lupus Nephritis urinary biomarker panel in children for use in a clinical trial. PhD thesis, University of Liverpool.


McCann, LJ, Pilkington, CA, Huber, AM, Ravelli, A, Appelbe, D, Kirkham, JJ ORCID: 0000-0003-2579-9325, Williamson, PR ORCID: 0000-0001-9802-6636, Aggarwal, A, Christopher-Stine, L, Constantin, T
et al (show 13 more authors) (2018) Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research. Annals of the rheumatic diseases, 77 (2). pp. 241-250.


Ambrose, N, Morgan, TA, Galloway, J, Ionnoau, Y, Beresford, MW ORCID: 0000-0002-5400-9911 and Isenberg, DA
(2016) Differences in disease phenotype and severity in SLE across age groups. LUPUS, 25 (14). pp. 1542-1550.


Donohue, SJ, Midgley, A, Davies, JC, Wright, RD ORCID: 0000-0002-7606-2297, Bruce, I, Beresford, MW ORCID: 0000-0002-5400-9911 and Hedrich, CM ORCID: 0000-0002-1295-6179
(2020) Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE). CLINICAL IMMUNOLOGY, 214. 108375-.


Smith, EMD, Jorgensen, AL ORCID: 0000-0002-6977-9337 and Beresford, MW ORCID: 0000-0002-5400-9911
(2017) Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study. Lupus, 26 (11). pp. 1212-1217.


Lythgoe, H, Morgan, T, Heaf, E, Lloyd, O and Beresford, MW ORCID: 0000-0002-5400-9911
(2016) EVALUATION OF THE ACR AND SLICC CLASSIFICATION CRITERIA IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS: A LONGITUDINAL ANALYSIS. .


Lythgoe, H, Morgan, T, Heaf, E, Lloyd, O, Al-Abadi, E, Armon, K, Bailey, K, Davidson, J, Friswell, M, Gardner-Medwin, J
et al (show 10 more authors) (2017) Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis. LUPUS, 26 (12). pp. 1285-1290.


Lythgoe, H, Price, V, Beresford, MW, Peak, M and Hawcutt, D ORCID: 0000-0002-8120-6507
(2016) G90(P) Research exposure for UK junior paediatric trainees. .


Hedrich, CM ORCID: 0000-0002-1295-6179, Beresford, MW ORCID: 0000-0002-5400-9911, Dedeoglu, F, Hahn, G, Hofmann, SR, Jansson, AF, Laxer, RM, Miettunen, P, Morbach, H, Pain, CE ORCID: 0000-0003-4965-3259
et al (show 8 more authors) (2023) Gathering expert consensus to inform a proposed trial in chronic nonbacterial osteomyelitis (CNO). CLINICAL IMMUNOLOGY, 251. 109344-.


Smith, EMD, Lewandowski, LB, Jorgensen, AL ORCID: 0000-0002-6977-9337, Phuti, A, Nourse, P, Scott, C and Beresford, MW ORCID: 0000-0002-5400-9911
(2018) Growing international evidence for urinary biomarker panels identifying lupus nephritis in children - verification within the South African Paediatric Lupus Cohort. LUPUS, 27 (14). pp. 2190-2199.


Dimou, P, Midgley, A, Peak, M ORCID: 0000-0003-1909-3211, Wright, RD ORCID: 0000-0002-7606-2297 and Beresford, MW ORCID: 0000-0002-5400-9911
(2016) INVESTIGATING THE NEUTROPHIL-MACROPHAGE INTERPLAY IN JUVENILE LUPUS NEPHRITIS PATHOGENESIS. .


Patel, M, Oni, L ORCID: 0000-0002-1532-2390, Midgley, A, Smith, E, Tullus, K, Marks, SD, Jones, CA, Pilkington, C and Beresford, MW ORCID: 0000-0002-5400-9911
(2016) Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis. LUPUS, 25 (9). pp. 1040-1044.


Midgley, A and Beresford, MW ORCID: 0000-0002-5400-9911
(2016) Increased expression of low density granulocytes in juvenile-onset systemic lupus erythematosus patients correlates with disease activity. LUPUS, 25 (4). pp. 407-411.


Oni, L ORCID: 0000-0002-1532-2390, Beresford, MW ORCID: 0000-0002-5400-9911, Witte, D, Chatzitolios, A, Sebire, N, Abulaban, K, Shukla, R, Ying, J and Brunner, HI
(2017) Inter-observer variability of the histological classification of lupus glomerulonephritis in children. LUPUS, 26 (11). pp. 1205-1211.


Smith, EMD, Jorgensen, AL ORCID: 0000-0002-6977-9337, Midgley, A, Oni, L ORCID: 0000-0002-1532-2390, Goilav, B, Putterman, C, Wahezi, D, Rubinstein, T, Ekdawy, D, Corkhill, R
et al (show 6 more authors) (2017) International validation of a urinary biomarker panel for identification of active lupus nephritis in children. Pediatric Nephrology, 32 (2). pp. 283-295.


Hedrich, CM ORCID: 0000-0002-1295-6179, Smith, EMD and Beresford, MW ORCID: 0000-0002-5400-9911
(2018) Juvenile-onset systemic lupus erythematosus (jSLE) - Pathophysiological concepts and treatment options. Best Practice and Research: Clinical Rheumatology, 31 (4). pp. 488-504.


Smith, EMD, Eleuteri, A ORCID: 0000-0003-0718-6672, Goilav, B, Lewandowski, L, Phuti, A, Rubinstein, T, Wahezi, D, Jones, CA, Marks, SD, Corkhill, R
et al (show 6 more authors) (2019) A Markov Multi-State model of lupus nephritis urine biomarker panel dynamics in children: Predicting changes in disease activity. CLINICAL IMMUNOLOGY, 198. pp. 71-78.


Oni, L ORCID: 0000-0002-1532-2390, Hawcutt, DB ORCID: 0000-0002-8120-6507, Turner, MA ORCID: 0000-0002-5299-8656, Beresford, MW ORCID: 0000-0002-5400-9911, McWilliam, S ORCID: 0000-0002-0509-7425, Barton, C, Park, BK ORCID: 0000-0001-8384-824X, Murray, P, Wilm, B ORCID: 0000-0002-9245-993X, Copple, I ORCID: 0000-0003-4101-1913
et al (show 4 more authors) (2017) Optimising the use of medicines to reduce acute kidney injury in children and babies. Pharmacology and Therapeutics, 174. pp. 55-62.


Smith, Emd, Al-Abadi, E, Armon, K, Bailey, K, Ciurtin, C, Davidson, J, Gardner-Medwin, J, Haslam, K, Hawley, D, Leahy, A
et al (show 13 more authors) (2019) Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis. Lupus, 28 (5). p. 961203319836712.


Ramos-Martín, V, Neely, MN, McGowan, P, Siner, S, Padmore, K, Peak, M ORCID: 0000-0003-1909-3211, Beresford, MW ORCID: 0000-0002-5400-9911, Turner, MA ORCID: 0000-0002-5299-8656, Paulus, S ORCID: 0000-0002-0703-9114 and Hope, WW ORCID: 0000-0001-6187-878X
(2016) Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy. The Journal of antimicrobial chemotherapy, 71 (11). pp. 3168-3178.


Ramos-Martin, V, Neely, MN, Padmore, K, Peak, M ORCID: 0000-0003-1909-3211, Beresford, MW ORCID: 0000-0002-5400-9911, Turner, MA ORCID: 0000-0002-5299-8656, Paulus, S ORCID: 0000-0002-0703-9114, Lopez-Herce, J and Hope, WW ORCID: 0000-0001-6187-878X
(2017) Tools for the Individualized Therapy of Teicoplanin for Neonates and Children. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61 (10). e00707-e00717.


Beresford, MW ORCID: 0000-0002-5400-9911, Kearsley-Fleet, L, Sampath, S, McCann, L, Baildam, E, Davies, R, De Cock, D, Foster, HE, Southwood, TR, Thomson, W
et al (show 1 more authors) (2018) Use and Effectiveness of Rituximab in Children with Juvenile Idiopathic Arthritis in a Real-World Cohort Study in the United Kingdom. Rheumatology (Oxford).


Attar, SG, Poustie, VJ, Hawcutt, DB ORCID: 0000-0002-8120-6507, Oni, L ORCID: 0000-0002-1532-2390, Beresford, MW ORCID: 0000-0002-5400-9911 and Pirmohamed, M ORCID: 0000-0002-7534-7266
(2019) Working together to deliver stratified medicine research effectively. British Medical Bulletin, 129 (1). pp. 107-116.


Peterknecht, E, Keasey, MP and Beresford, MW ORCID: 0000-0002-5400-9911
(2018) The effectiveness and safety of biological therapeutics in juvenile-onset systemic lupus erythematosus (JSLE): a systematic review. LUPUS, 27 (13). pp. 2135-2145.

This list was generated on Tue Apr 16 03:56:30 2024 BST.